GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortrea Holdings Inc (MEX:FTRE1) » Definitions » EBIT

Fortrea Holdings (MEX:FTRE1) EBIT : MXN-1,551 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Fortrea Holdings EBIT?

Fortrea Holdings's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was MXN-264 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was MXN-1,551 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Fortrea Holdings's annualized ROC % for the quarter that ended in Sep. 2024 was -0.65%. Fortrea Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -32.08%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Fortrea Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -2.70%.


Fortrea Holdings EBIT Historical Data

The historical data trend for Fortrea Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortrea Holdings EBIT Chart

Fortrea Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EBIT
2,038.93 2,802.21 4,624.45 1,203.47

Fortrea Holdings Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 221.22 195.20 -687.09 -795.09 -263.85

Competitive Comparison of Fortrea Holdings's EBIT

For the Biotechnology subindustry, Fortrea Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fortrea Holdings's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortrea Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Fortrea Holdings's EV-to-EBIT falls into.



Fortrea Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-1,551 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fortrea Holdings  (MEX:FTRE1) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Fortrea Holdings's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=-724.604 * ( 1 - 48.32% )/( (54075.448 + 60994.642)/ 2 )
=-374.4753472/57535.045
=-0.65 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=65318.495 - 8931.05 - ( 2311.997 - max(0, 13721.757 - 16262.755+2311.997))
=54075.448

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=72139.352 - 9071.321 - ( 2073.389 - max(0, 15669.541 - 18447.842+2073.389))
=60994.642

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Fortrea Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1055.4/( ( (3171.21 + max(-9594.239, 0)) + (3408.391 + max(-9512.385, 0)) )/ 2 )
=-1055.4/( ( 3171.21 + 3408.391 )/ 2 )
=-1055.4/3289.8005
=-32.08 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1615.833 + 0 + 2264.364) - (8931.05 + 4543.386 + 0)
=-9594.239

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3075.625 + 0 + 2805.867) - (9071.321 + 6322.555 + 0.00099999999838474)
=-9512.385

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Fortrea Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=-1550.823/57353.955
=-2.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fortrea Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Fortrea Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Fortrea Holdings Business Description

Comparable Companies
Traded in Other Exchanges
Address
8 Moore Drive, Durham, NC, USA, 27709
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Fortrea Holdings Headlines

No Headlines